Site Management/Investigator Payments Featured Articles
-
PI's CRAACO Model + AI = Rapid Enrollment
6/30/2025
At Dr. David Almeida’s clinical trial site in Erie, PA, he practices the CRAACO model exclusively, relying on the revenue he makes from conducting clinical trials for eye-related diseases. To minimize his costs and speed up trial enrollment, he uses a proprietary AI system that has given him an 85% screen-to-enroll ratio.
-
It's Time To Change How We Engage Research Sites
6/25/2025
Site operations expert Maria Ladd argues for a major change in how sponsors and CROs communicate and work with clinical research sites.
-
Why CRA Proficiency Needs A Boost From Better Assessment And Training
6/20/2025
CRAs intend to fulfill clinical research’s commitment to patient safety. Yet, some fall short of true proficiency, and Gerald DeWolfe contends better evaluations and training can help.
-
5 Ways To Make Your Investigator Meetings Fun And Functional
6/17/2025
Discover five ways CROs and sponsors can better engage and communicate with site staff for better relationships and better trials.
-
Hidden Compliance Risks In Start-Up That Could Derail Your Clinical Trial
6/13/2025
Kulkarni Law Firm Senior Attorney Edye T. Edens explores the risks embedded in clinical trial start-up activities, such as site activation, contract execution, delegation of responsibilities, and cross-border data flows.
-
J&J Survey Of Oncologists Reveals Challenges With Awareness & Access
6/12/2025
J&J President, U.S. Solid Tumor Biljana Naumovic discusses the company's Oncology Care Index, which revealed issues with oncology provider awareness of and access to clinical trials.
-
Improving Recruitment Needs More Than Transactional Fixes To Earn Patient Trust
6/11/2025
Driving patient recruitment and retention in clinical trials isn't always about scheduling, transportation, or even reimbursement. Often, and especially for marginalized communities, it begins with trust.
-
U.S. Tariffs And Their Tenuous Impact On Clinical Trials
6/10/2025
RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.
-
When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover
6/6/2025
Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. shares a near-catastrophic CRO experience and explains how his team rebounded just in time.
-
Nurturing Clinical Site Relationships Drives Trial Success
6/3/2025
Whether a clinical trial is studying rare disease therapies or large-volume vaccines, three Ps define the approach to site feasibility: patients, product, and procedures. Advanced technological and methodological tools can assist sponsors, CROs, and sites in identifying fruitful collaborations, but person-to-person discussion and communication must drive those collaborations.